These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
166 related articles for article (PubMed ID: 2119366)
1. Enhancement by cysteinyl thiols of acetyltransferase-mediated, but not of sulfotransferase-mediated, binding of a pyrolysate-derived N-hydroxyarylamine, 2-hydroxyamino-6-methyldipyrido[1,2-a:3',2'-d]imidazole, to DNA. Abu-Zeid M; Staiano N; Yamazoe Y; Kato R Jpn J Cancer Res; 1990; 81(6-7):653-9. PubMed ID: 2119366 [TBL] [Abstract][Full Text] [Related]
2. Sulfotransferase-mediated DNA binding of N-hydroxyarylamines(amide) in liver cytosols from human and experimental animals. Abu-Zeid M; Yamazoe Y; Kato R Carcinogenesis; 1992 Aug; 13(8):1307-14. PubMed ID: 1499081 [TBL] [Abstract][Full Text] [Related]
3. Enzymatic acetylation and sulfation of N-hydroxyarylamines in bacteria and rat livers. Yamazoe Y; Abu-Zeid M; Gong DW; Staiano N; Kato R Carcinogenesis; 1989 Sep; 10(9):1675-9. PubMed ID: 2670304 [TBL] [Abstract][Full Text] [Related]
4. DNA binding of N-hydroxy-Trp-P-2 and N-hydroxy-Glu-P-1 by acetyl-CoA dependent enzyme in mammalian liver cytosol. Shinohara A; Saito K; Yamazoe Y; Kamataki T; Kato R Carcinogenesis; 1985 Feb; 6(2):305-7. PubMed ID: 3971494 [TBL] [Abstract][Full Text] [Related]
5. Acetyl coenzyme A dependent activation of N-hydroxy derivatives of carcinogenic arylamines: mechanism of activation, species difference, tissue distribution, and acetyl donor specificity. Shinohara A; Saito K; Yamazoe Y; Kamataki T; Kato R Cancer Res; 1986 Sep; 46(9):4362-7. PubMed ID: 3731093 [TBL] [Abstract][Full Text] [Related]
6. Effect of rat liver cytosolic enzymes and cofactors on mutagenicity of 1-amino-8-nitropyrene. Martire G; Villani GR; Della Morte R; Belisario MA; Pecce R; Staiano N Carcinogenesis; 1991 Feb; 12(2):361-4. PubMed ID: 1995197 [TBL] [Abstract][Full Text] [Related]
7. A new assay for N-hydroxyarylamine O-acetyltransferase: reduction of N-hydroxyarylamines through N-acetoxyarylamines. Saito K; Shinohara A; Kamataki T; Kato R Anal Biochem; 1986 Feb; 152(2):226-31. PubMed ID: 3516004 [TBL] [Abstract][Full Text] [Related]
8. Inhibition of acetyl-coenzyme A dependent activation of N-hydroxyarylamines by phenolic compounds, pentachlorophenol and 1-nitro-2-naphthol. Shinohara A; Saito K; Yamazoe Y; Kamataki T; Kato R Chem Biol Interact; 1986 Dec; 60(3):275-85. PubMed ID: 3791493 [TBL] [Abstract][Full Text] [Related]
9. Enzymatic phase II activation of the N-hydroxylamines of IQ, MeIQx and PhIP by various organs of monkeys and rats. Davis CD; Schut HA; Snyderwine EG Carcinogenesis; 1993 Oct; 14(10):2091-6. PubMed ID: 8222059 [TBL] [Abstract][Full Text] [Related]
10. Role of sulfation and acetylation in the activation of 2-hydroxyamino-1-methyl-6-phenylimidazo[4,5-b]pyridine to intermediates which bind DNA. Buonarati MH; Turteltaub KW; Shen NH; Felton JS Mutat Res; 1990 Nov; 245(3):185-90. PubMed ID: 2233839 [TBL] [Abstract][Full Text] [Related]
11. Activation and detoxication of carcinogenic arylamines by sulfation. Yamazoe Y; Nagata K; Ozawa S; Gong DW; Kato R Princess Takamatsu Symp; 1995; 23():154-62. PubMed ID: 8844806 [TBL] [Abstract][Full Text] [Related]
12. Acetyl coenzyme A-dependent metabolic activation of N-hydroxy-3,2'-dimethyl-4-aminobiphenyl and several carcinogenic N-hydroxy arylamines in relation to tissue and species differences, other acyl donors, and arylhydroxamic acid-dependent acyltransferases. Flammang TJ; Kadlubar FF Carcinogenesis; 1986 Jun; 7(6):919-26. PubMed ID: 3708755 [TBL] [Abstract][Full Text] [Related]
13. Metabolic activation of mutagenic N-hydroxyarylamines by O-acetyltransferase in Salmonella typhimurium TA98. Saito K; Shinohara A; Kamataki T; Kato R Arch Biochem Biophys; 1985 May; 239(1):286-95. PubMed ID: 3890753 [TBL] [Abstract][Full Text] [Related]
14. Activation of chromium(VI) by thiols results in chromium(V) formation, chromium binding to DNA and altered DNA conformation. Borges KM; Boswell JS; Liebross RH; Wetterhahn KE Carcinogenesis; 1991 Apr; 12(4):551-61. PubMed ID: 1849467 [TBL] [Abstract][Full Text] [Related]
15. Properties of cutaneous acetyltransferase catalyzing N- and O-acetylation of carcinogenic arylamines and N-hydroxyarylamine. Kawakubo Y; Manabe S; Yamazoe Y; Nishikawa T; Kato R Biochem Pharmacol; 1988 Jan; 37(2):265-70. PubMed ID: 3342083 [TBL] [Abstract][Full Text] [Related]
16. Metabolic activation of N-hydroxy arylamines and N-hydroxy heterocyclic amines by human sulfotransferase(s). Chou HC; Lang NP; Kadlubar FF Cancer Res; 1995 Feb; 55(3):525-9. PubMed ID: 7834621 [TBL] [Abstract][Full Text] [Related]
17. Activation of 2-hydroxyamino-1-methyl-6-phenylimidazo[4,5-b] pyridine by cDNA-expressed human and rat arylsulfotransferases. Ozawa S; Chou HC; Kadlubar FF; Nagata K; Yamazoe Y; Kato R Jpn J Cancer Res; 1994 Dec; 85(12):1220-8. PubMed ID: 7852185 [TBL] [Abstract][Full Text] [Related]
18. In vitro activation of 2-aminobenzyl alcohol and 2-amino-6-nitrobenzyl alcohol, metabolites of 2-nitrotoluene and 2,6-dinitrotoluene. Chism JP; Rickert DE Chem Res Toxicol; 1989; 2(3):150-6. PubMed ID: 2519719 [TBL] [Abstract][Full Text] [Related]
19. Mutagenicity and in vitro covalent DNA binding of 2-hydroxyamino-3-methylimidazolo[4,5-f]quinoline. Snyderwine EG; Wirth PJ; Roller PP; Adamson RH; Sato S; Thorgeirsson SS Carcinogenesis; 1988 Mar; 9(3):411-8. PubMed ID: 3162208 [TBL] [Abstract][Full Text] [Related]
20. Metabolic activation of carcinogenic heterocyclic aromatic amines by human liver and colon. Turesky RJ; Lang NP; Butler MA; Teitel CH; Kadlubar FF Carcinogenesis; 1991 Oct; 12(10):1839-45. PubMed ID: 1934265 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]